论文部分内容阅读
乙型病毒性肝炎(简称乙肝)在中国广泛流行,严重危害着居民的健康。国内1992年实施儿童乙肝疫苗免疫接种;2002年将其纳入免疫规划。免疫策略的实施对建立人体免疫屏障起到了积极有效的推动作用。为及时了解国内乙肝病毒免疫学研究新成果,掌握疫苗等生物制剂在人群中的应用情况,在查阅大量文献的基础上,结合新疆自治区及兵团相关部门提供的数据,对国内乙肝免疫学研究新进展进行了综合分析。
Hepatitis B virus (referred to as hepatitis B) is widely prevalent in China, seriously endangering the health of residents. In 1992, China implemented hepatitis B immunization for children; in 2002, it was included in the immunization program. The implementation of the immunization strategy has played a positive and effective role in promoting the human immune barrier. In order to keep abreast of new achievements in the study of hepatitis B virus immunology in China and to master the application of biological agents such as vaccines in the population, based on a large amount of literature and data from related departments of Xinjiang Autonomous Region and Corps, Progress made a comprehensive analysis.